High serum levels of calcitonin are not pathognomonic of medullary thyroid carcinoma and may indicate polyglandular autoimmune syndrome III
Mazokopakis, E.E.; Karefilakis, C.M.; Batistakis, A.G.; Syros, P.K.; Kalathas, T.G.; Starakis, I.K.
Hellenic Journal of Nuclear Medicine 13(1): 67-68
2010
ISSN/ISBN: 1790-5427 PMID: 20411177 Document Number: 642248
Document emailed within 1 workday
Related Documents
Miyauchi, A.; Matsuzuka, F.; Kuma, K.; Takai, S.; Maeda, M. 1987: Assessment of surgical treatments of medullary thyroid carcinoma by analysis of serum calcitonin levels Nihon Geka Gakkai Zasshi 88(1): 102-108Łacka, K.; Michałek, K.; Majewski, P.ła. 2002: Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse Wiadomosci Lekarskie 55(7-8): 394-403
Roos, B.A.; Deftos, L.J.; Roberts, G.; Wilson, P.; Bundy, L. 1976: Radioimmunoassay of calcitonin in plasma, normal thyroid, and medullary thyroid carcinoma of the rat Journal of Laboratory and Clinical Medicine 88(2): 173-182
Dambacher, M.A.; Guncaga, J.; Heitz, P.; Haas, H.G. 1973: Calcitonin and the medullary thyroid carcinoma Therapeutische Umschau. Revue Therapeutique 30(10): 740-746
Sesti, A.; Mayerhoefer, M.; Weber, M.; Anner, P.; Wadsak, W.; Dudczak, R.; Haug, A.; Karanikas, G. 2014: Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET Anticancer Research 34(11): 6647-6654
Zeytinoglu, F.N.; Gagel, R.F.; DeLellis, R.A.; Wolfe, H.J.; Tashjian, A.H.; Hammer, R.A.; Leeman, S.E. 1983: Clonal strains of rat medullary thyroid carcinoma cells that produce neurotensin and calcitonin. Functional and morphologic studies Laboratory Investigation; a Journal of Technical Methods and Pathology 49(4): 453-459
Heath, H.; Sizemore, G.W. 1979: Immunochemical heterogeneity of calcitonin in tumor, tumor venous effluent, and peripheral blood of patients with medullary thyroid carcinoma Journal of Laboratory and Clinical Medicine 93(3): 390-401
Ishikawa, T. 2006: Autoimmune polyglandular syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl 2: 49-52
Tucker, L.E.; O'Neal, L.W.; Martin, S.A. 1984: Pseudocarcinoid syndrome due to medullary carcinoma of the thyroid Missouri Medicine 81(9): 607-608; 620
Joshi, R.R.; Rao, S.; Prabhu, S.S. 2006: Polyglandular autoimmune syndrome-type i Indian Pediatrics 43(12): 1085-1087
Matoussi, N.; Aissa, K.; Fitouri, Z.; Makni, S.; Ben Becher, S. 2008: Autoimmune polyglandular syndrome type i La Tunisie Medicale 86(5): 519-520
Császár, T.; Patakfalvi, A. 1993: Polyglandular autoimmune syndrome type Ii Orvosi Hetilap 134(29): 1591-1593
Nagy, G.; Minik, K.; Ujszászy, L.; Csák, L. 1972: Pheochromocytoma and medullary thyroid carcinoma (Sipple's syndrome) Orvosi Hetilap 113(53): 3205-3208
Netzloff, M.L.; Garnica, A.D.; Rodgers, B.M.; Frias, J.L. 1979: Medullary carcinoma of the thyroid in the multiple mucosal neuromas syndrome Annals of Clinical and Laboratory Science 9(5): 368-373
Azad, A.K.; Islam, M.S.; Quayum, S.L. 2015: Autoimmune polyglandular syndrome type II - a case report Mymensingh Medical Journal: Mmj 24(1): 199-201
Restivo, N. 2012: You're the flight surgeon: autoimmune polyglandular syndrome type 2 Aviation Space and Environmental Medicine 83(8): 816-817
Siewert, E.; Silvestri, A.; Riehl, J.; Mertens, P.R. 2001: 32-year old patient presenting with autoimmune polyglandular syndrome European Journal of Medical Research 6(1): 21-26
Pérez Corral, B.; Ugarte, E.; Piniés, J.A.; Vázquez, J.A. 1995: Is Addison disease predictable in polyglandular type i autoimmune syndrome? Medicina Clinica 104(7): 277-278
Dave, P.; Bhosle, D.; Dharme, M.; Deshmukh, D.; Patel, J. 2015: Autoimmune Polyglandular Syndrome Type 2 with Alopecia Universalis and Hypoparathyroidism Journal of the Association of Physicians of India 63(4): 74-76
Patier, J.L.; Calleja, J.L.; Lorente, J.A.; de Pablo, R. 1992: Shock with 2 concomitant causes: sudden onset of autoimmune polyglandular syndrome type Ii Revista Clinica Espanola 191(2): 113-114